Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03369418 · ClinicalTrials.gov registry record · NA
Effectiveness of CES on Emotional and Cellular Wellbeing
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT03369418 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 44 participants.
The verdict
NCT03369418, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The investigators aim to use a CES (cranial electrotherapy stimulation) intervention to improve emotional well-being by reducing symptoms of anxiety and depression and to assess for changes in markers of cellular health - specifically, telomere length and telomerase activity
Interventions
- DEVICE Alpha-Stim Active
- DEVICE Alpha-Stim Inactive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-03 |
| Est. Completion | 2018-10-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03369418
The ClinicalTrials.gov registry entry for NCT03369418 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Alpha-Stim Active is the first listed.
NCT03369418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03369418 about?
NCT03369418 is a clinical study titled "Effectiveness of CES on Emotional and Cellular Wellbeing". The investigators aim to use a CES (cranial electrotherapy stimulation) intervention to improve emotional well-being by reducing symptoms of anxiety and depression and to assess for changes in markers of cellular health - specifically, telomere length and telomerase activity
What is the current status of trial NCT03369418?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2016-03. Estimated completion is 2018-10-20.
What interventions are being tested in trial NCT03369418?
The interventions under investigation include: Alpha-Stim Active (DEVICE), Alpha-Stim Inactive (DEVICE).
Who is sponsoring clinical trial NCT03369418?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.